Yuko Hirota

1.7k total citations
38 papers, 1.3k citations indexed

About

Yuko Hirota is a scholar working on Molecular Biology, Epidemiology and Cell Biology. According to data from OpenAlex, Yuko Hirota has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Epidemiology and 9 papers in Cell Biology. Recurrent topics in Yuko Hirota's work include Autophagy in Disease and Therapy (10 papers), Cellular transport and secretion (7 papers) and Erythrocyte Function and Pathophysiology (5 papers). Yuko Hirota is often cited by papers focused on Autophagy in Disease and Therapy (10 papers), Cellular transport and secretion (7 papers) and Erythrocyte Function and Pathophysiology (5 papers). Yuko Hirota collaborates with scholars based in Japan, Australia and United States. Yuko Hirota's co-authors include Tomotake Kanki, Dongchon Kang, Tetsu Saigusa, Yusuke Kurihara, Yoshimasa Aoki, Takeshi Uchiumi, Yoshitaka Tanaka, M. Aihara, Yoshitaka Tanaka and Hideaki Fujita and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yuko Hirota

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Hirota Japan 17 731 727 352 158 118 38 1.3k
Yoshihiro Tagawa Japan 6 501 0.7× 804 1.1× 248 0.7× 151 1.0× 84 0.7× 18 1.2k
Kevin F. Bryant United States 9 728 1.0× 542 0.7× 791 2.2× 96 0.6× 76 0.6× 10 1.5k
Vikramjit Lahiri India 10 582 0.8× 823 1.1× 267 0.8× 132 0.8× 69 0.6× 19 1.3k
Yinfeng Xu China 15 702 1.0× 775 1.1× 175 0.5× 112 0.7× 38 0.3× 31 1.4k
Yaïr Botbol United States 10 408 0.6× 568 0.8× 129 0.4× 181 1.1× 33 0.3× 13 966
Tsuyoshi Kawabata Japan 16 779 1.1× 836 1.1× 299 0.8× 136 0.9× 36 0.3× 28 1.6k
Alexis Rozenknop Germany 5 754 1.0× 998 1.4× 299 0.8× 171 1.1× 129 1.1× 6 1.3k
Weiliang Fan United States 11 988 1.4× 1.5k 2.1× 582 1.7× 214 1.4× 77 0.7× 15 2.0k
Chieko Kishi‐Itakura United Kingdom 10 751 1.0× 1.5k 2.0× 640 1.8× 269 1.7× 145 1.2× 11 1.9k

Countries citing papers authored by Yuko Hirota

Since Specialization
Citations

This map shows the geographic impact of Yuko Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Hirota more than expected).

Fields of papers citing papers by Yuko Hirota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Hirota. The network helps show where Yuko Hirota may publish in the future.

Co-authorship network of co-authors of Yuko Hirota

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Hirota. A scholar is included among the top collaborators of Yuko Hirota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Hirota. Yuko Hirota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Xing, Takumi Ishida, Renshi Li, et al.. (2025). Ablation of Mouse Selenium-Binding Protein 1 and 2 Elevates LDL by Disruption of Cholesterol Efflux and Lipid Metabolism. International Journal of Molecular Sciences. 26(7). 3363–3363. 1 indexed citations
2.
Shimizu, Akinori, Bin Chou, Ryota Itoh, et al.. (2025). Mycobacterium abscessus resides within lipid droplets and acquires a dormancy-like phenotype in adipocytes. Biochemical and Biophysical Research Communications. 758. 151645–151645.
3.
Hirota, Yuko, et al.. (2021). LAPTM4α is targeted from the Golgi to late endosomes/lysosomes in a manner dependent on the E3 ubiquitin ligase Nedd4-1 and ESCRT proteins. Biochemical and Biophysical Research Communications. 556. 9–15. 1 indexed citations
4.
Hirota, Yuko, et al.. (2020). The carboxyl-terminal di-lysine motif is essential for catalytic activity of UDP-glucuronosyltransferase 1A9. Drug Metabolism and Pharmacokinetics. 35(5). 466–474. 3 indexed citations
5.
Ishii, Yuji, et al.. (2020). Lysosomal integral membrane protein LGP85 (LIMP-2) is ubiquitinated at the N-terminal cytoplasmic domain. Biochemical and Biophysical Research Communications. 524(2). 424–430.
6.
Hirota, Yuko, et al.. (2020). The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer. Breast Cancer. 27(4). 586–593. 2 indexed citations
7.
Hirota, Yuko, et al.. (2019). Investigation of the Endoplasmic Reticulum Localization of UDP-Glucuronosyltransferase 2B7 with Systematic Deletion Mutants. Molecular Pharmacology. 95(5). 551–562. 7 indexed citations
8.
Tozaki, Mitsuhiro, Seigo Nakamura, Yoshimi Ide, et al.. (2019). The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan. Breast Cancer. 26(5). 552–561. 16 indexed citations
9.
Ida, Hiroaki, et al.. (2015). Intracellular Dynamics and Fate of a Humanized Anti–Interleukin-6 Receptor Monoclonal Antibody, Tocilizumab. Molecular Pharmacology. 88(4). 660–675. 14 indexed citations
10.
Hirota, Yuko, Yusuke Kurihara, M. Aihara, et al.. (2015). Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy. 11(2). 332–343. 167 indexed citations
11.
Aihara, M., Yusuke Kurihara, Yutaka Yoshida, et al.. (2014). The Tor and Sin3-Rpd3 complex regulate expression of the mitophagy receptor protein Atg32. Journal of Cell Science. 127(Pt 14). 3184–96. 38 indexed citations
12.
Akashi‐Tanaka, Sadako, Chie Watanabe, Takashi Kuwayama, et al.. (2014). BRCAness Predicts Resistance to Taxane-Containing Regimens in Triple Negative Breast Cancer During Neoadjuvant Chemotherapy. Clinical Breast Cancer. 15(1). 80–85. 44 indexed citations
13.
Kanki, Tomotake, Yusuke Kurihara, Tadahiro Goda, et al.. (2013). Casein kinase 2 is essential for mitophagy. EMBO Reports. 14(9). 788–794. 116 indexed citations
14.
Hirota, Yuko, Yoshimasa Aoki, & Tomotake Kanki. (2011). [Mitophagy: selective degradation of mitochondria by autophagy].. PubMed. 83(2). 126–30. 10 indexed citations
15.
Aoki, Yoshimasa, Tomotake Kanki, Yuko Hirota, et al.. (2011). Phosphorylation of Serine 114 on Atg32 mediates mitophagy. Molecular Biology of the Cell. 22(17). 3206–3217. 171 indexed citations
16.
Hirota, Yuko & Yoshitaka Tanaka. (2009). A small GTPase, human Rab32, is required for the formation of autophagic vacuoles under basal conditions. Cellular and Molecular Life Sciences. 66(17). 2913–2932. 85 indexed citations
17.
Ikeda, Kazuhiko, et al.. (2008). Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes. Biochemical and Biophysical Research Communications. 377(1). 268–274. 43 indexed citations
18.
Kuronita, Toshio, Toshiyuki Hatano, Yuko Hirota, et al.. (2005). The NH2‐Terminal Transmembrane and Lumenal Domains of LGP85 are Needed for the Formation of Enlarged Endosomes/Lysosomes. Traffic. 6(10). 895–906. 21 indexed citations
19.
Hirota, Yuko, et al.. (2004). 3-Methyladenine specifically inhibits retrograde transport of cation-independent mannose 6-phosphate/insulin-like growth factor II receptor from the early endosome to the TGN. Biochemical and Biophysical Research Communications. 316(3). 845–852. 17 indexed citations
20.
Takeo, Satoshi, et al.. (2003). Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury. Biochemical Pharmacology. 67(3). 565–574. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihiro Tagawa Breakdown of academic impact, for papers by Kevin F. Bryant Breakdown of academic impact, for papers by Vikramjit Lahiri Breakdown of academic impact, for papers by Yinfeng Xu Breakdown of academic impact, for papers by Yaïr Botbol Breakdown of academic impact, for papers by Tsuyoshi Kawabata Breakdown of academic impact, for papers by Alexis Rozenknop Breakdown of academic impact, for papers by Weiliang Fan Breakdown of academic impact, for papers by Chieko Kishi‐Itakura
Rankless by CCL
2026